ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212,273 | -71.2% | 7,900 | -61.5% | 0.00% | – |
| Q2 2023 | $736,565 | +210950.1% | 20,500 | +43.4% | 0.00% | -100.0% |
| Q1 2023 | $349 | -78.2% | 14,300 | -63.7% | 0.00% | -66.7% |
| Q4 2022 | $1,598 | -99.8% | 39,400 | +79.9% | 0.00% | +200.0% |
| Q3 2022 | $729,000 | +7.0% | 21,900 | +11.2% | 0.00% | 0.0% |
| Q2 2022 | $681,000 | -51.6% | 19,700 | -36.2% | 0.00% | 0.0% |
| Q1 2022 | $1,407,000 | -74.0% | 30,869 | -61.6% | 0.00% | -83.3% |
| Q4 2021 | $5,415,000 | -6.3% | 80,400 | -59.7% | 0.01% | -64.7% |
| Q1 2020 | $5,778,000 | -70.8% | 199,446 | -35.3% | 0.02% | -64.6% |
| Q4 2019 | $19,789,000 | +162.6% | 308,227 | +10.3% | 0.05% | +118.2% |
| Q3 2019 | $7,536,000 | -10.0% | 279,518 | -11.5% | 0.02% | -8.3% |
| Q2 2019 | $8,371,000 | +277.4% | 315,872 | +161.4% | 0.02% | +242.9% |
| Q1 2019 | $2,218,000 | +20.0% | 120,844 | -22.0% | 0.01% | +40.0% |
| Q4 2018 | $1,849,000 | -59.6% | 154,857 | -35.2% | 0.01% | -50.0% |
| Q3 2018 | $4,578,000 | +664.3% | 238,800 | +187.4% | 0.01% | +400.0% |
| Q2 2018 | $599,000 | 0.0% | 83,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $599,000 | +246.2% | 83,100 | +76.8% | 0.00% | – |
| Q4 2017 | $173,000 | -72.2% | 47,000 | -67.3% | 0.00% | -100.0% |
| Q3 2017 | $622,000 | +460.4% | 143,611 | +103.6% | 0.00% | – |
| Q2 2017 | $111,000 | -32.7% | 70,553 | -19.4% | 0.00% | – |
| Q1 2017 | $165,000 | -1.8% | 87,569 | -19.4% | 0.00% | – |
| Q4 2016 | $168,000 | -81.5% | 108,700 | -12.7% | 0.00% | -100.0% |
| Q3 2016 | $909,000 | +36.1% | 124,500 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $668,000 | – | 123,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Tygh Capital Management, Inc. | 63,947 | $4,240,000 | 0.60% |